期刊文献+

亚细胞蛋白质组学技术分析MG132诱导HL-60细胞G_2/M期阻滞的分子机制 被引量:5

Proteomic Analysis of G_2/M Arrest of HL-60 Cells Induced by MG132
下载PDF
导出
摘要 背景与目的:蛋白酶体抑制剂能够诱导多种肿瘤细胞凋亡,是一种有应用前景的抗肿瘤制剂。本研究通过对蛋白酶体抑制剂——MG132诱导G2/M期阻滞的HL-60细胞核蛋白进行蛋白质组学分析,探索参与HL-60细胞G2/M期阻滞调控的相关蛋白。方法:流式细胞术分析MG132处理的HL-60细胞周期,选取合适的时间点,提取细胞核,光镜和Westernblot检测细胞核纯度,裂解制样,通过二维电泳和MALDI-TOF-TOF串联质谱分析,鉴定表达显著差异的细胞核蛋白。结果:HL-60细胞在被2.5μmol/LMG132诱导凋亡之前8h,有明显的G2/M期阻滞发生;提取阻滞发生时和阻滞发生前的HL-60细胞核蛋白,二维电泳分析获得23个差异表达的蛋白点,质谱鉴定了8个核蛋白。结论:质谱鉴定的eIF5A、mRNA前体剪接因子等蛋白可能参与HL-60细胞的G2/M周期阻滞调控,为研究蛋白酶体抑制剂诱导白血病细胞周期阻滞及凋亡的分子机制提供了一些线索。 BACKGROUND & OBJECTIVE. Proteasome inhibitor, which can induce apoptosis in various tumor cells, is a kind of potential antitumor drug. This study was to identify the proteins involved in G2/M arrest of leukemia cell line HL-60 exposed to proteasome inhibitor MG132 by proteomic techniques. METHODS: Flow cytometry was used to examine cell cycle of HL-60 cells exposed to 2.5 μmol/L MG132. Nuclear extracts of HL-60 cells were prepared, and the purity was detected by light microscopy and Western blot, and the differentially expressed protein spots were dertermined by two-dimensional gel electrophoresis and identified with MALDI-TOF-TOF/MS. RESULTS.. There was a distinct G2/M phase arrest before the apoptosis of HL-60 cells induced by 2.5 μmol/L MG132. Twentythree differentially expressed protein spots were found between MG132- treated and control HL-60 cells; 8 nuclear proteins were identified by MALDI- TOF-TOF/MS analysis. CONCLUSIONS: The detected proteins, such as elF5A and splicing factor, may be involved in regulation of G2/M arrest of HL-60 cells. These findings will be helpful for revealing molecular mechanisms of proteasome inhibitor-induced G2/M phase arrest and apoptosis of leukemia cell line.
出处 《癌症》 SCIE CAS CSCD 北大核心 2006年第5期533-537,共5页 Chinese Journal of Cancer
基金 国家自然科学基金资助项目(No.30100223 No.30170291)~~
关键词 蛋白酶体抑制剂 HL-60细胞 细胞周期 细胞核蛋白 蛋白质组 Proteasome inhibitor HL-60 cells Cell cycle Nuclear extract Proteome
  • 相关文献

参考文献16

  • 1Kastan M B, Bartek J. Cell-cycle checkpoints and cancer [J].Nature, 2004,432(7015) :316-323.
  • 2Ohta T, Fukuda M. Ubiquitin and breast cancer [J].Oncogene, 2004,23 ( 11 ) : 2079-2088.
  • 3Adams J. Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer [J]. Curr Opin Chem Biol, 2002,6(4) :493-500.
  • 4Wilkins M R, Sanchez J C, Cooley A A, et al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it [J]. Biotechnol Genet Eng Rev, 1996,13:19-50.
  • 5Blackstock W P, Weir M P. Proteomics: quantitative and physical mapping of cellular proteins [ J ]. Trends Biotechnol,1999,17(3) : 121-127.
  • 6孙国敬,钱俊杰,孟祥兵,宋宜,张枫,梅柱中,董燕,孙志贤.蛋白酶体抑制剂MG132诱导HL-60细胞凋亡前G_2/M期阻滞及机制[J].癌症,2004,23(10):1144-1148. 被引量:12
  • 7斯佩克特,戈德曼,莱因万德,黄培堂,等译.细胞实验指南(上册)[M].北京:科学出版社,2004:374—375.
  • 8Rabilloud T, Adessi C, Giraudel A, et al. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients [J]. Electrophoresis, 1997,18(3-4) :307-316.
  • 9Blomberg A, Blomberg L, Norbeck J, et al. Interlaboratory reproducibility of yeast protein patterns analyzed by immobilized pH gradient two-dimensional gel electrophoresis[J]. Electrophoresis, 1995,16(10) : 1935-1945.
  • 10谢玲,应万涛,李邦印,张开泰,钱小红,项晓琼,吴德昌.蛋白质组学技术识别Maspin在支气管上皮永生化细胞和恶性转化细胞中的差异表达[J].癌症,2003,22(5):463-466. 被引量:6

二级参考文献15

  • 1Kumatori A, Tanaka K, Inamura N, et al. Abnormally high expression of proteasomes in human leukemic cells [J]. Proc Natl Acad Sci USA, 1990, 87 (18): 7071-7075.
  • 2Banerjee D, Liefshitz A. Potential of the proteasomal inhibitor MG-132 as an anticancer agent, alone and in combination [J].Anticancer Res,2001, 21 (6A): 3941-3947.
  • 3Soligo D, Servida F, Delia D, et al. The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI [J]. Br J Haematol,2001,113(1):126-135.
  • 4Hu B, Zhou XY, Wang X, et al. The radioresistance to killing of A1-5 cells derives from activation of the Chk1 pathway [J]. J Biol Chem, 2001, 276 (21): 17693-17698.
  • 5Chowdhury IH, Wang XF, Landau NR, et al. HIV-1 Vpr activates cell cycle inhibitor p21/Wafl/Cip: a potential mechanism of G2/M cell cycle arrest [J]. Virology, 2003, 305(2): 371-377.
  • 6Ando T, Kawabe T, Ohara H, et al. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage [J]. J Biol Chem,2001, 276 (46): 42971-42977.
  • 7Taylor WR, Stark GR. Regulation of the G2/M transition by p53[J]. Oncogene,2001, 20 (15): 1803-1815.
  • 8Wasinger VC, Cordwell SJ, Cerpa-Poljak A, et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium[J]. Electrophoresis, 1995, 16: 1090-1094.
  • 9Zou Z, Anisowica A, Hendrix MJC, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells[ J ]. Science, 1994, 263:526 - 529.
  • 10Maass N, Hojo T, Zhang M, et al. Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer [J].Acta Oncol, 2000, 39:931 - 934.

共引文献16

同被引文献34

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部